share_log

Metropolitan Life Insurance Co NY Sells 52,197 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Metropolitan Life Insurance Co NY Sells 52,197 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

纽约大都会人寿保险公司出售52,197股Option Care Health，Inc.(纳斯达克代码：OPCH)
Defense World ·  2022/09/08 05:32

Metropolitan Life Insurance Co NY decreased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) by 84.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,734 shares of the company's stock after selling 52,197 shares during the quarter. Metropolitan Life Insurance Co NY's holdings in Option Care Health were worth $278,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

根据纽约大都会人寿保险公司最近提交给美国证券交易委员会(美国证券交易委员会)的文件，该公司第一季度减持了Option Care Health，Inc.(美国证券交易委员会代码：OPCH-GET评级)的股票84.3%。该公司在本季度出售了52,197股后，拥有9,734股该公司的股票。截至最近提交给美国证券交易委员会(SEC)的文件，纽约大都会人寿保险公司持有的Option Care Health价值27.8,000美元。

Several other institutional investors have also recently made changes to their positions in OPCH. State Street Corp lifted its holdings in Option Care Health by 8.4% during the 4th quarter. State Street Corp now owns 4,406,306 shares of the company's stock worth $125,315,000 after purchasing an additional 341,158 shares in the last quarter. Marshall Wace LLP bought a new position in Option Care Health in the fourth quarter valued at $85,991,000. Nuveen Asset Management LLC raised its position in Option Care Health by 1.8% during the fourth quarter. Nuveen Asset Management LLC now owns 2,937,263 shares of the company's stock valued at $83,536,000 after purchasing an additional 53,279 shares in the last quarter. Geode Capital Management LLC lifted its stake in Option Care Health by 7.1% during the fourth quarter. Geode Capital Management LLC now owns 2,688,710 shares of the company's stock worth $76,466,000 after purchasing an additional 177,890 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Option Care Health by 8.2% during the 1st quarter. JPMorgan Chase & Co. now owns 2,200,320 shares of the company's stock valued at $62,840,000 after purchasing an additional 167,399 shares during the last quarter. Hedge funds and other institutional investors own 92.58% of the company's stock.

其他几个机构投资者最近也改变了他们在禁毒办的头寸。道富银行在第四季度增持了8.4%的Option Care Health股票。道富银行目前持有4,406,306股该公司股票，价值125,315,000美元，上一季度又购买了341,158股。马歇尔·华斯有限责任公司在第四季度以85,991,000美元的价格购买了Option Care Health的新头寸。Nuveen Asset Management LLC在第四季度将其在Option Care Health的头寸提高了1.8%。Nuveen Asset Management LLC在上个季度额外购买了53,279股后，现在拥有2,937,263股该公司股票，价值83,536,000美元。Geode Capital Management LLC在第四季度增持了Option Care Health 7.1%的股份。Geode Capital Management LLC现在拥有该公司2,688,710股股票，价值76,466,000美元，上个季度又购买了177,890股。最后，摩根大通在第一季度增持了Option Care Health股票8.2%。摩根大通在上季度购买了167,399股摩根大通股票后，目前持有该公司2,200,320股股票，价值62,840,000美元。对冲基金和其他机构投资者持有该公司92.58%的股票。

Get
到达
Option Care Health
Option Care Health
alerts:
警报：

Analyst Ratings Changes

分析师评级发生变化

Several analysts have issued reports on the company. Lake Street Capital upped their target price on Option Care Health from $35.00 to $45.00 in a research note on Thursday, July 28th. Barrington Research increased their target price on shares of Option Care Health from $33.00 to $37.00 and gave the company an "outperform" rating in a report on Thursday, July 28th. The Goldman Sachs Group lifted their price target on Option Care Health from $31.00 to $40.00 and gave the stock a "buy" rating in a research note on Monday, August 22nd. Finally, TheStreet upgraded shares of Option Care Health from a "c+" rating to a "b" rating in a report on Monday, June 6th.

几位分析师已经发布了关于该公司的报告。Lake Street Capital在7月28日星期四的一份研究报告中将Option Care Health的目标价从35.00美元上调至45.00美元。Barrington Research在7月28日周四的一份报告中将Option Care Health的股票目标价从33.00美元上调至37.00美元，并给予该公司“跑赢大盘”的评级。8月22日，高盛夫妇在一份研究报告中将其期权Care Health的目标价从31.00美元上调至40.00美元，并给予该股“买入”评级。最后，华尔街在6月6日星期一的一份报告中将Option Care Health的股票评级从“c+”上调至“b”。

Insider Transactions at Option Care Health

Option Care Health的内幕交易

In other Option Care Health news, major shareholder Walgreens Boots Alliance, Inc. sold 11,000,000 shares of the company's stock in a transaction dated Tuesday, August 16th. The shares were sold at an average price of $33.01, for a total value of $363,110,000.00. Following the sale, the insider now owns 26,247,092 shares in the company, valued at $866,416,506.92. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, Director R Carter Pate sold 1,923 shares of Option Care Health stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $33.37, for a total value of $64,170.51. Following the completion of the transaction, the director now owns 99,381 shares of the company's stock, valued at approximately $3,316,343.97. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, major shareholder Walgreens Boots Alliance, Inc. sold 11,000,000 shares of the stock in a transaction dated Tuesday, August 16th. The shares were sold at an average price of $33.01, for a total transaction of $363,110,000.00. Following the sale, the insider now directly owns 26,247,092 shares in the company, valued at $866,416,506.92. The disclosure for this sale can be found here. Insiders have sold 11,003,846 shares of company stock valued at $363,231,861 in the last three months. 0.22% of the stock is currently owned by company insiders.
在Option Care Health的其他消息中，大股东Walgreens Boots Alliance，Inc.在日期为8月16日(星期二)的交易中出售了11,000,000股该公司股票。这些股票的平均价格为33.01美元，总价值为363,110,000.00美元。出售后，这位内部人士现在拥有该公司26,247,092股，价值866,416,506.92美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可以在美国证券交易委员会的网站上看到。在其他新闻方面，董事R卡特·佩特在一笔日期为8月1日(星期一)的交易中出售了1,923股期权Care Health股票。这只股票的平均售价为33.37美元，总价值为64,170.51美元。交易完成后，董事现在拥有99,381股该公司股票，价值约3,316,343.97美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可以通过美国证券交易委员会网站获得。此外，大股东Walgreens Boots Alliance，Inc.在8月16日星期二的交易中出售了11,000,000股该股。这些股票以33.01美元的平均价格出售，总成交金额为363,110,000.00美元。出售后，这位内部人士现在直接拥有该公司26,247,092股，价值866,416,506.92美元。此次拍卖的披露信息可在此处找到。在过去的三个月里，内部人士已经出售了11,003,846股公司股票，价值363,231,861美元。公司内部人士目前持有该公司0.22%的股份。

Option Care Health Trading Up 2.4 %

期权医疗保健交易上涨2.4%

OPCH opened at $32.50 on Thursday. Option Care Health, Inc. has a one year low of $21.32 and a one year high of $35.57. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.58 and a quick ratio of 1.16. The business has a 50 day simple moving average of $31.91 and a two-hundred day simple moving average of $29.20. The firm has a market capitalization of $5.91 billion, a price-to-earnings ratio of 33.51, a PEG ratio of 2.86 and a beta of 1.34.

OPCH周四开盘报32.50美元。Option Care Health，Inc.的一年低点为21.32美元，一年高位为35.57美元。该公司的债务权益比为0.82，流动比率为1.58，速动比率为1.16。该业务的50日简单移动均线切入位为31.91美元，200日简单移动均线切入位为29.20美元。该公司市值为59.1亿美元，市盈率为33.51倍，市盈率为2.86倍，贝塔系数为1.34。

Option Care Health (NASDAQ:OPCH – Get Rating) last announced its earnings results on Wednesday, July 27th. The company reported $0.19 EPS for the quarter, missing analysts' consensus estimates of $0.22 by ($0.03). The business had revenue of $980.80 million for the quarter, compared to the consensus estimate of $940.93 million. Option Care Health had a net margin of 4.71% and a return on equity of 12.11%. Option Care Health's revenue was up 14.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.18 EPS. Analysts predict that Option Care Health, Inc. will post 0.78 EPS for the current year.

Options Care Health(纳斯达克代码：OPCH-GET Rating)最近一次公布财报是在7月27日(星期三)。该公司公布本季度每股收益为0.19美元，低于分析师普遍预期的0.22美元(0.03美元)。该业务本季度的收入为9.80亿美元，而普遍预期为9.4093亿美元。Option Care Health的净利润率为4.71%，股本回报率为12.11%。Option Care Health的收入与去年同期相比增长了14.0%。去年同一季度，该公司每股收益为0.18美元。分析师预测，Option Care Health，Inc.本年度每股收益将为0.78美元。

Option Care Health Profile

选项护理健康配置文件

(Get Rating)

(获取评级)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Option Care Health，Inc.在美国提供家庭和备用地点输液服务。该公司提供抗感染治疗；治疗心力衰竭的家庭输液服务；治疗中风、癌症和胃肠道疾病等多种急慢性疾病的家庭非肠道营养和肠内营养支持服务；治疗免疫缺陷的免疫球蛋白输注疗法；以及治疗慢性炎症性疾病的治疗，包括克罗恩病、斑块状牛皮癣、牛皮癣关节炎、类风湿性关节炎、溃疡性结肠炎和其他慢性炎症性疾病。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
  • 3 High Margin Chipmakers Bound to Recover
  • 3 Solar Stocks That Will Benefit From the Biden Tariff Holiday
  • REV Group Has A Deep Moat In The World Of EVs
  • Is G-III Apparel Group, Ltd. A Value Trap?
  • Bank Of America Sees Upside In These 2 European Alcohol Stocks
  • 免费获取StockNews.com关于选项护理健康(OPCH)的研究报告
  • 3家高利润率芯片制造商势必复苏
  • 将受益于拜登关税假期的3只太阳能股
  • REV集团在电动汽车世界拥有深厚的护城河
  • G-III服装集团有限公司是价值陷阱吗？
  • 美国银行看好这两只欧洲酒类股票

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.

接受《每日健康选择》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯，接收对Option Care Health和相关公司的最新新闻和分析师评级的简要每日摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发